Novo Nordisk A/S
Reinvesting dividends added $140.56 extra to your Novo Nordisk A/S investment over this period.
| Ex-Date | Dividend | Reinvest Price | Shares Added |
|---|---|---|---|
| 2025-03-31 | $0.82 | $69.44 | +0.011795 |
| 2025-08-18 | $0.41 | $53.75 | +0.007747 |
Novo Nordisk A/S (NVO) is a dividend-paying stock. Over the past year, the company paid 2 dividends totaling $1.2306 per share. When these dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform. The calculation accounts for the compounding effect where reinvested dividends generate their own future dividends.
Novo Nordisk A/S (NVO) delivered a total return of -26.67% over the past year when dividends are reinvested. The price-only return was -28.08%, meaning dividends contributed an additional 1.41 percentage points to total returns.
A $10,000 investment in Novo Nordisk A/S one year ago would be worth $7,333 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $7,192. Dividend reinvestment added $141 to the portfolio value.
Yes, Novo Nordisk A/S (NVO) pays dividends. Over the past year, NVO paid 2 dividends totaling $1.2306 per share. Reinvesting these dividends through a DRIP can significantly boost long-term returns.
Screen for dividend stocks with the highest total returns (including DRIP). See which dividend stocks actually grow your wealth.
Calculate total returns for related stocks: